Literature DB >> 25576674

Deletion of Nrf2 reduces skeletal mechanical properties and decreases load-driven bone formation.

Yong-Xin Sun1, Lei Li2, Kylie A Corry3, Pei Zhang3, Yang Yang4, Evan Himes3, Cristina Layla Mihuti3, Cecilia Nelson3, Guoli Dai3, Jiliang Li5.   

Abstract

Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor expressed in many cell types, including osteoblasts, osteocytes, and osteoclasts. Nrf2 has been considered a master regulator of cytoprotective genes against oxidative and chemical insults. The lack of Nrf2 can induce pathologies in multiple organs. The aim of this study was to investigate the role of Nrf2 in load-driven bone metabolism using Nrf2 knockout (KO) mice. Compared to age-matched littermate wild-type controls, Nrf2 KO mice have significantly lowered femoral bone mineral density (-7%, p<0.05), bone formation rate (-40%, p<0.05), as well as ultimate force (-11%, p<0.01). The ulna loading experiment showed that Nrf2 KO mice were less responsive than littermate controls, as indicated by reduction in relative mineralizing surface (rMS/BS, -69%, p<0.01) and relative bone formation rate (rBFR/BS, -84%, p<0.01). Furthermore, deletion of Nrf2 suppressed the load-driven gene expression of antioxidant enzymes and Wnt5a in cultured primary osteoblasts. Taken together, the results suggest that the loss-of-function mutation of Nrf2 in bone impairs bone metabolism and diminishes load-driven bone formation.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomechanics; Bone formation; Mechanotransduction; Nrf2; Osteoblast; Wnt5a

Mesh:

Substances:

Year:  2015        PMID: 25576674     DOI: 10.1016/j.bone.2014.12.066

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  21 in total

Review 1.  Bone Homeostasis and Repair: Forced Into Shape.

Authors:  Alesha B Castillo; Philipp Leucht
Journal:  Curr Rheumatol Rep       Date:  2015-09       Impact factor: 4.592

2.  Monomethylfumarate protects against ovariectomy-related changes in body composition.

Authors:  Anna E Bollag; Tianyang Guo; Ke-Hong Ding; Vivek Choudhary; Xunsheng Chen; QIng Zhong; Jianrui Xu; Kanglun Yu; Mohamed E Awad; Mohammed Elsalanty; Maribeth H Johnson; Meghan E McGee-Lawrence; Wendy B Bollag; Carlos M Isales
Journal:  J Endocrinol       Date:  2019-07-01       Impact factor: 4.286

3.  Absence of Dipeptidyl Peptidase 3 Increases Oxidative Stress and Causes Bone Loss.

Authors:  Ciro Menale; Lisa J Robinson; Eleonora Palagano; Rosita Rigoni; Marco Erreni; Alejandro J Almarza; Dario Strina; Stefano Mantero; Michela Lizier; Antonella Forlino; Roberta Besio; Marta Monari; Paolo Vezzoni; Barbara Cassani; Harry C Blair; Anna Villa; Cristina Sobacchi
Journal:  J Bone Miner Res       Date:  2019-09-09       Impact factor: 6.741

4.  Orexin-A Reverse Bone Mass Loss Induced by Chronic Intermittent Hypoxia Through OX1R-Nrf2/HIF-1α Pathway.

Authors:  Hong Gu; Yiwen Ru; Wei Wang; Guanhui Cai; Lanxin Gu; Junjie Ye; Wei-Bing Zhang; Lin Wang
Journal:  Drug Des Devel Ther       Date:  2022-07-05       Impact factor: 4.319

Review 5.  Regulatory Role of Nrf2 Signaling Pathway in Wound Healing Process.

Authors:  Ipek Süntar; Sümeyra Çetinkaya; Emiliano Panieri; Sarmistha Saha; Brigitta Buttari; Elisabetta Profumo; Luciano Saso
Journal:  Molecules       Date:  2021-04-21       Impact factor: 4.411

Review 6.  Role of Nrf2 in bone metabolism.

Authors:  Yong-Xin Sun; Ai-Hua Xu; Yang Yang; Jiliang Li
Journal:  J Biomed Sci       Date:  2015-10-29       Impact factor: 8.410

7.  Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner.

Authors:  Gretel G Pellegrini; Cynthya C Morales; Taylor C Wallace; Lilian I Plotkin; Teresita Bellido
Journal:  Nutrients       Date:  2016-07-11       Impact factor: 5.717

8.  Nrf2 regulates mass accrual and the antioxidant endogenous response in bone differently depending on the sex and age.

Authors:  Gretel Gisela Pellegrini; Meloney Cregor; Kevin McAndrews; Cynthya Carolina Morales; Linda Doyle McCabe; George P McCabe; Munro Peacock; David Burr; Connie Weaver; Teresita Bellido
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

9.  Dimethyl fumarate inhibits osteoclasts via attenuation of reactive oxygen species signalling by augmented antioxidation.

Authors:  Yuuki Yamaguchi; Hiroyuki Kanzaki; Yuta Katsumata; Kanako Itohiya; Sari Fukaya; Yutaka Miyamoto; Tsuyoshi Narimiya; Satoshi Wada; Yoshiki Nakamura
Journal:  J Cell Mol Med       Date:  2017-10-24       Impact factor: 5.310

10.  Shockwave Treatment Enhanced Extracellular Matrix Production in Articular Chondrocytes Through Activation of the ROS/MAPK/Nrf2 Signaling Pathway.

Authors:  Po-Chih Shen; Shih-Hsiang Chou; Cheng-Chang Lu; Hsuan-Ti Huang; Song-Hsiung Chien; Peng-Ju Huang; Zi-Miao Liu; Chia-Lung Shih; Shu-Jem Su; Li-Min Chen; Yin-Chun Tien
Journal:  Cartilage       Date:  2021-07-08       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.